Similarly, the progress of fibrosis in SSc was attenuated by applying RNAi to inhibit the transcription factor Fra-2 of the ERK signalling pathway between TGF-β1 and PDGF [20]. The gene discussed is FOSL2; the disease is systemic sclerosis.